Cosette Pharmaceuticals Launches First Injectable Product – Prochlorperazine Edisylate Injection in the U.S.

Launch Further Diversifies Cosette’s Product Offerings In-Line with Growth…


Cosette Pharmaceuticals Acquires Rights to Eight Branded Products from Daiichi Sankyo

Transformational Transaction Diversifies Cosette’s Business to Accelerate…


Mindy Hanna has joined Cosette Pharmaceuticals as Senior Director, Human Resources

We are pleased to announce Mindy Hanna has joined Cosette Pharmaceuticals as…


Solaris Pharma Receives Approval for First Generic Version of Clindagel® (clindamycin phosphate EQ 1%)

BRIDGEWATER, N.J., Aug. 23, 2021 (GLOBE NEWSWIRE) — Solaris Pharma Corporation…


Cosette Pharmaceuticals, Inc. Announces FDA Approval of ANDA for Hydrocortisone Valerate Cream USP, 0.2%

Bridgewater, NJ (March 04, 2021) – Cosette Pharmaceuticals, Inc., a New…


Cosette Pharmaceuticals Appoints Seasoned Industry Executive Apurva Saraf as President and Chief Executive Officer

Bridgewater, NJ (July 14, 2020) – “We are very pleased to welcome Apurva to the…